Related Experiment Video
Updated: Apr 6, 2026
09:18
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
917
Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models
Daniel L J Thorek1, Robin M Kramer2, Qing Chen3
1Division of Nuclear Medicine, The Russell H. Morgan Department of Radiology and Radiological Sciences, The Johns Hopkins School of Medicine, Baltimore, MD.
Summary
This study demonstrates a novel method for delivering radiation therapy to mouse pancreatic tumors using computed tomography (CT) and a rotating gantry. This approach minimizes damage to healthy tissue and significantly slows tumor growth in preclinical models.
Area of Science:
- Medical physics
- Preclinical oncology research
- Radiation oncology
Background:
- Pancreatic cancer research requires effective preclinical models.
- Accurate imaging and targeted radiation delivery are crucial for effective treatment.
- Existing methods may lack precision in small animal models.
Purpose of the Study:
- To assess the feasibility of experimental radiation therapy for mouse pancreatic tumors.
- To utilize combined computed tomography (CT) and orthovoltage treatment with a rotating gantry.
- To establish a method for precise radiation delivery in preclinical pancreatic cancer models.
Main Methods:
- Abdominal organ delineation using X-ray CT after contrast administration.
- Validation of CT imaging against magnetic resonance imaging (MRI).
- Delivery of 15 Gy radiation therapy via a 1-cm diameter field using a rotating gantry, confirmed by γH2AX staining.
Main Results:
- The developed strategy enables clinical radiation oncology approaches in small animal models.
- Delivery of 15 Gy from a rotating gantry minimizes damage to surrounding healthy tissue.
- Significant retardation of tumor growth was observed after treatment.
Conclusions:
- This technique allows for the evaluation of radiation planning and dosing parameters in preclinical settings.
- Accurate, noninvasive longitudinal imaging and monitoring of tumor progression and response are now feasible.
- This advance is expected to improve the evaluation of pancreatic cancer and therapeutic responses in preclinical models.
